---
categories: 
- Database
- Release
date: 2020-12-03
title: Database release
github_url: https://github.com/vanallenlab/moalmanac-db/releases/tag/v.2020-12-03
---
Added entries:
- (FDA) _RET_ somatic variants associated with sensitivity to pralsetinib in advanced or metastatic medullary thyroid cancer. 
- (FDA) _RET_ fusions associated with sensitivity to pralsetinib in advanced or metastatic thyroid cancer.
- (Inferential) _CDK274_ amplifications associated with sensitivity to chemotherapy in combination with pembrolizumab in locally recurrent or metastatic triple-negative breast cancer.

Edited entries:
- (Guideline) _CDK4_ amplifications associated with sensitivity to palbociclib in well-differentiated and dedifferentiated liposarcoma, updated source. 
- (Guideline) _KIT_ somatic variants associated with sensitivity to sunitinib in thymic carcinomas, updated source. 

Removed entries:
- (Preclinical) _CDKN2B_ deletions associated with sensitivity to EPZ015666.